Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim: To asess ...

Screening by faecal occult blood testing (FOBT) has been shown to be effective in reducing colorectal cancer (CRC) mortality (Mandel et al, 1993; Selby et al, 1993; Saito et al, 1995; Hardcastle et al ...

1. A Single Office-Based Stool Blood Test (FOBT) Is a Poor, but Often Used, Screening Test for Colorectal Cancer Two articles and an editorial in the Jan. 18, 2005, Annals of Internal Medicine discuss ...

TO THE EDITORS:In the July issue of The American Journal of Managed Care, Schroy et al 1 reported on preferences for colorectal cancer (CRC) screening tests in relation to currently recommended ...

The inexpensive tests that look for hidden blood in a person's stool are effective for colon cancer screening, a study confirms. The findings, reported in the Canadian Medical Association Journal, ...

Epidemiologist Wendy Atkin from Imperial College London explains how a revolution in bowel cancer screening could drastically cut the death rate. It involves examining the lower third of the bowel, ...

NEW YORK (Reuters Health) - The inexpensive stool tests commonly used to screen for colon cancer can be more effective, and much less costly, than newer tests that look for certain genetic markers in ...

The global fecal occult testing market grew at a CAGR of around 5% during 2015-2020. A fecal occult blood test (FOBT) is a noninvasive procedure used to detect hidden blood in the feces or stool. It ...

Objective: To assess patient preferences for 1 of the recommended colorectal cancer screening options or stool DNA testing (sDNA), a novel noninvasive screening test. Study Design: Cross-sectional ...

A systematic search was conducted to retrieve studies that investigated the accuracy of FOBT in patients taking ASA or warfarin. We identified potential English-language sources from the Pubmed, ...